Combinatorial antitumor effects of amino acids and epigenetic modulations in hepatocellular carcinoma cell lines
- 20 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (11), 2245-2257
- https://doi.org/10.1007/s00210-021-02140-z
Abstract
Hepatocellular carcinoma (HCC) is a highly fatal form of liver cancer. Recently, the interest in using amino acids as therapeutic agents has noticeably grown. The present work aimed to evaluate the possible antiproliferative effects of selected amino acids supplementation or deprivation in human HCC cell lines and to investigate their effects on critical signaling molecules in HCC pathogenesis and the outcomes of their combination with the histone deacetylase inhibitor vorinostat. HepG2 and Huh7 cells were treated with different concentrations of l-leucine, l-glutamine, or l-methionine and cell viability was determined using MTT assay. Insulin-like growth factor 1 (IGF1), phosphorylated ribosomal protein S6 kinase (p70 S6K), p53, and cyclin D1 (CD1) protein levels were assayed using ELISA. Caspase-3 activity was assessed colorimetrically. l-leucine supplementation (0.8–102.4 mM) and l-glutamine supplementation (4–128 mM) showed dose-dependent antiproliferative effects in both cell lines but l-methionine supplementation (0.2–25.6 mM) only affected the viability of HepG2 cells. Glutamine or methionine deprivation suppressed the proliferation of HepG2 cells whereas leucine deprivation had no effect on cell viability in both cell lines. The combination between the effective antiproliferative changes in l-leucine, l-glutamine, and l-methionine concentrations greatly suppressed cell viability and increased the sensitivity to vorinostat in both cell lines. The growth inhibitory effects were paralleled with significant decreases in IGF-1, phospho p70 S6k, and CD1 levels and significant elevations in p53 and caspase-3 activity. Changes in amino acids concentrations could profoundly affect growth in HCC cell lines and their response to epigenetic therapy.Keywords
This publication has 78 references indexed in Scilit:
- Branched-Chain Amino Acids Enhance Premature Senescence through Mammalian Target of Rapamycin Complex I-Mediated Upregulation of p21 ProteinPLOS ONE, 2013
- The Complex Role of Branched Chain Amino Acids in Diabetes and CancerMetabolites, 2013
- Effects of leucine and its metabolite β‐hydroxy‐β‐methylbutyrate on human skeletal muscle protein metabolismJournal Of Physiology-London, 2013
- Glutaminolysis Activates Rag-mTORC1 SignalingMolecular Cell, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling PathwayPLOS ONE, 2011
- Defective Regulation of Autophagy upon Leucine Deprivation Reveals a Targetable Liability of Human Melanoma Cells In Vitro and In VivoCancer Cell, 2011
- Metabolic regulation by p53Journal of Molecular Medicine, 2011
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002